Kadia, T. M., Cortes, J., Ravandi, F., Jabbour, E., Konopleva, M., Benton, C. B., . . . Kantarjian, H. (2018). Phase II Single-Arm Trial of Cladribine and Low-Dose Cytarabine Alternating with Decitabine as Frontline Therapy for Older Patients with Acute Myeloid Leukemia. Lancet Haematol.
Citação norma ChicagoKadia, Tapan M., et al. "Phase II Single-Arm Trial of Cladribine and Low-Dose Cytarabine Alternating With Decitabine As Frontline Therapy for Older Patients With Acute Myeloid Leukemia." Lancet Haematol 2018.
MLA CitationKadia, Tapan M., et al. "Phase II Single-Arm Trial of Cladribine and Low-Dose Cytarabine Alternating With Decitabine As Frontline Therapy for Older Patients With Acute Myeloid Leukemia." Lancet Haematol 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.